Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

Enbridge (ENB) Q2 Earnings Top Estimates, Revenues Surge Y/Y

Published 08/01/2019, 09:26 PM
Updated 07/09/2023, 06:31 AM
ENB
-

An Earnings Beat: Energy infrastructure provider Enbridge Inc (NYSE:ENB) reported second-quarter 2019 adjusted earnings per share of 51 cents, higher than the Zacks Consensus Estimate of 42 cents.

Estimate Revision Trend: Investors should note that the Zacks Consensus Estimate for the quarter has been revised downwards in the last seven days.

Enbridge Inc Price and EPS Surprise

Enbridge Inc price-eps-surprise | Enbridge Inc Quote

Revenue Increases: Enbridge reported revenues of C$13.3 billion, higher than the year-earlier sales of C$10.7 billion.

Zacks Rank & Surprise History: Currently, Enbridge carries a Zacks Rank #3 (Hold), which is subject to change following the earnings announcement.

(You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.)

Coming to earnings surprise history, the company has an excellent record: it has not missed estimates in any of the last four quarters.

Key Stats: Liquids Pipelines: Operating income at this segment was C$1,992 million, up from C$1,322 million a year ago.

Gas Transmission and Midstream: The segment reported earnings of C$941 million, down from C$1,014 million in second-quarter 2018.

Gas Distribution: This business unit reported profit of C$390 million, up from C$370 million in the June quarter of 2018.

Check back later for our full write up on this Enbridge earnings report later!

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Enbridge Inc (ENB): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.